NANOVIRICIDES
NanoViricides, Inc. is a nano-biopharmaceutical company whose business goals are to discover, develop and commercialize therapeutics (nanoviricidesâ„¢) to advance the care of patients suffering from life-threatening viral infections.
NANOVIRICIDES
Industry:
Biopharma Biotechnology Medical
Founded:
2005-01-01
Address:
West Haven, Connecticut, United States
Country:
United States
Website Url:
http://www.nanoviricides.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
48.5 M USD
Technology used in webpage:
SPF Apache AJAX Libraries API COVID-19 Sectigo SSL Sectigo Domain SSL Google Analytics Classic Bizland IPOWER DNS
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Milton Boniuk
Milton Boniuk investment in Post-IPO Debt - NanoViricides
Seaside 88
Seaside 88 investment in Post-IPO Equity - NanoViricides
Official Site Inspections
http://www.nanoviricides.com
- Host name: 47.132.96.66.static.eigbox.net
- IP address: 66.96.132.47
- Location: Burlington United States
- Latitude: 42.509
- Longitude: -71.1984
- Metro Code: 506
- Timezone: America/New_York
- Postal: 01803
More informations about "NanoViricides"
Corporate Information - nanoviricides.com
NanoViricides is also unique in the bio-pharma field in that it possesses its own state of the art facilities for the design, synthesis, analysis and characterization of the nanomedicines that we develop, as well as for production scale-up, and c …See details»
About Us | NanoViricides
NanoViricides, Inc. is a global leader in the development of nanomedicine drugs against viruses. Our unique nanoviricide® platform technology defines a novel mechanism enabling first-in …See details»
Home | NanoViricides
Mar 28, 2025 Broad-spectrum nanoviricides have been created that can bind to possibly as many as 90-95% of known viruses. The Company is developing broad-spectrum nanoviricides …See details»
NanoViricides - Crunchbase Company Profile & Funding
Organization. NanoViricides . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. ...See details»
NanoViricides, Inc. - LinkedIn
NanoViricides, Inc. | 319 followers on LinkedIn. Bind - Encapsulate - Destroy | Official LinkedIn Page of NanoViricides, Inc NanoViricides, Inc. is a global leader in the development of ...See details»
NanoViricides - LifeScienceHistory.com
NanoViricides www.nanoviricides.com. 1 Controls Drive. Shelton, CT 6484. Company Info Phone (203) 937-6137 Year Established 2000 Ticker NNVC Exchange OTCBB. Contacts Anil R. …See details»
NanoViricides Company Profile - Craft
Oct 21, 2024 NanoViricides, Inc. is a development stage company with a unique nanomedicine technology. The Company is developing nanotechnology-based biomimetic anti-viral …See details»
NanoViricides, Inc. | Life Sciences PA
NanoViricides, Inc. is a global leader in the development of nanomedicine drugs against viruses. Our unique nanoviricide® platform technology defines a novel mechanism enabling first-in …See details»
NanoViricides - VentureRadar
NanoViricides, Inc. is a development stage company with a unique nanomedicine technology. The Company is developing nanotechnology-based biomimetic anti-viral medicines, that we call …See details»
Investor Info - nanoviricides.com
May 7, 2024 NanoViricides, Inc. is a leading company in the application of nanomedicine technologies to the complex issues of viral diseases. The nanoviricide® technology permits …See details»
NanoViricides - Overview, News & Similar companies - ZoomInfo
NanoViricides, Inc. to Present at The Inaugural Ef Hutton Global Conference on May 10, 2023 in New York City SHELTON, Conn., May 04, 2023 (GLOBE NEWSWIRE) -- (via IBN) -- …See details»
NanoViricides taps clinical research organization for Phase II trial …
Jan 27, 2025 NanoViricides (NYSE-A:NNVC) said on Monday it had engaged a clinical research organization to conduct a Phase II trial for its broad-spectrum antiviral drug NV-387. The …See details»
NanoViricides, Inc. - Cruelty Free Investing
NanoViricides, Inc. is a nano-biopharmaceutical company. The company engages in the discovery, development, and commercialization of therapeutics to advance the care of patients …See details»
NanoViricides, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
SHELTON, CT / ACCESSWIRE / December 23, 2024 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), says that its broad-spectrum antiviral drug candidate NV …See details»
NanoViricides targets key milestones in 2025 with NV-387 …
Feb 19, 2025 NanoViricides has now engaged a Clinical Research Organization (CRO) to oversee the Phase II trial for MPox, with trial sites identified in two African countries. Beyond …See details»
2023-06-05 NanoViricides Inc Fact Sheet
||Page&2of 4.Ver.20230604||. Global,’Strong,’Pioneering,’Intellectual’Property’with’Runway’Beyond’2040 ...See details»
NanoViricides Drug Can Fight Bird Flu Pandemic; H5N1
Feb 11, 2025 NanoViricides' platform technology and programs are based on the TheraCour® nanomedicine technology of TheraCour, which TheraCour licenses from AllExcel. ... WHO is …See details»
NANOVIRICIDES, INC.
NANOVIRICIDES, INC. (Name of Business Issuer in Its Charter) NEVADA. 76-0674577 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 1 …See details»
NanoViricides taps clinical research organization for Phase II trial …
Jan 27, 2025 NanoViricides (NYSE-A:NNVC) said on Monday it had engaged a clinical research organization to conduct a Phase II trial for its broad-spectrum antiviral drug NV-387. The …See details»
Molecular nanocages remove 80-90% of PFAS, or 'forever …
6 days ago Researchers funded by the U.S. National Science Foundation have created a molecular nanocage that captures the bulk of per- and polyfluoroalkyl substances, or PFAS, …See details»